SYSTEMIC EFFECTS OF MONOCLONAL ANTIBODIES USED FOR ATOPIC DERMATITIS AND PSORIASIS AND THEIR ROLE FOR CONCOMITANT CHRONIC RESPIRATORY DISEASES